StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AKSHARCHEM.NS$188.06-1.23%
Fair $188.06+0.0%

AKSHARCHEM.NS

AksharChem (India) Limited

Basic Materials / Specialty ChemicalsNSE

$188.06

-2.35 (-1.23%)

Fairly Valued+0.0%Fair Value $188.06Fund rank 24/100 · Data gapFallback financials|
SA 15/F
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-234.0M · quality 39.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 10/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

15/100

F

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -0.2%, below the 5% threshold
Thesis & Journal · AKSHARCHEM.NSLocal privado en este navegador · AksharChem (India) Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.5B

P/E

N/A

•

EV/EBITDA

13.7x

↑

ROE

-0.2%

↑

Gross Margin

40.1%

↑

Debt/Equity

0.41

↑
52-Week Range$188
$141$331

TradingView lightweight chart

AKSHARCHEM.NS price, volumen y niveles de valoración

Último $188.06Periodo -74.2%
Fair value: $188.06

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+4.7%

FCF CAGR

—

FCF margin

-9.2%

FCF / Net income

78.17x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.72B · net income $-4.4M · FCF $-342.9M

2023-FY → 2026-FY

Gross margin

40.1%+10.0% pts

Operating margin

0.1%+0.3% pts

Net margin

-0.1%+0.2% pts

FCF margin

-9.2%-18.1% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$3.72B$3.72B$3.46B$3.02B$3.25B
Net Income$-4.4M$-4.4M$47.7M$-186.8M$-9.4M
EBITDA$189.0M$189.0M$250.9M$15.1M$150.7M
EPS-0.55-0.555.94-23.25-1.17
Gross Margin40.1%40.1%42.8%37.0%30.1%
Operating Margin0.1%0.1%3.1%-2.6%-0.2%
Net Margin-0.1%-0.1%1.4%-6.2%-0.3%
Balance Sheet
Debt/Equity0.410.410.250.200.09
Current Ratio0.990.99———
Cash Flow
Free Cash Flow$-342.9M$-342.9M$-93.8M$-234.0M$290.2M
Returns
ROE-0.2%-0.2%1.8%-7.2%-0.3%
Valuation
P/E——36.04——
EV/EBITDA13.6613.669.51182.1313.43
P/B0.570.570.650.860.64
Growth & Yield
Revenue Growth7.6%7.6%14.6%-7.0%—
EPS Growth-109.3%-109.3%125.5%-1887.2%—
Dividend Yield0.4%0.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -28.8%

Total return

-28.8%

Start / end P/E

n/dx → n/dx

EPS bridge

5.94 → -0.55

Residual

-29.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.4%
Residual / FX / buybacks / cross-term-29.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.